James Cheon to head Ahngook’s global business division

Published: 2012-06-20 06:56:00

Updated: 2012-06-20 06:56:00

Ahngook Pharmaceutical Co said Monday it has appointed as its new executive director, James Cheon (S.Y. Cheon), a renowned expert in pharmaceutical licensing and foreign business.

James will take charge of boosting Ahngook’s new drugs and others in the global arena that the company has been re...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK